Physician profile
Steven C Downing
NPI 1336123199
$1,058.33
in general payments reported to CMS, 2019-2025
18 companies · $80.43 in 2025
The $80.43 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $28.66 · 2021: $60.07 · 2022: $298 · 2023: $315 · 2024: $169 · 2025: $80.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $160.58 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $157.00 | 2022-2025 | Jardiance, Mounjaro, Emgality |
| Amgen INC. | $146.54 | 2019-2025 | Otezla, Repatha, Repatha |
| Pfizer INC. | $99.35 | 2019-2023 | |
| Abbvie INC. | $95.34 | 2022-2024 | Vraylar |
| Sanofi-Aventis U.S. LLC | $74.68 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $45.20 | 2022 | |
| Philips North America LLC | $42.74 | 2019 | |
| Novo Nordisk INC | $37.85 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.80 | 2022 | |
| Glaxosmithkline, LLC. | $31.26 | 2023 | Shingrix, Arexvy |
| Astellas Pharma US INC | $30.72 | 2023-2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $19.79 | 2022 | |
| Xeris Pharmaceuticals, INC. | $17.69 | 2024 | Gvoke Hypopen |
| Vanda Pharmaceuticals INC. | $17.17 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $16.56 | 2023 | Quviviq |
| Hologic Sales and Service, LLC | $16.20 | 2020 | |
| Nestle Healthcare Nutrition INC. | $14.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Downing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.